
Mirae Asset Healthcare Fund Analyst Review: NAV, Returns and Key Insights 2026
Updated: 2 Jun 2026 • 2:11 pm
Posted by:

Offering a 1-year return of 16.39% and a 3-month gain of 7.39%, the Mirae Asset Healthcare Fund provides investors with measured exposure to its underlying investment universe. The fund manages Rs 2,939.23 crore in assets at a NAV of Rs 47.9. This review breaks down its returns history, expense structure, and who should consider adding it to their portfolio in 2026.
Click Here – Get Mutual Fund Advisory
What Is the Mirae Asset Healthcare Fund?
The Mirae Asset Healthcare Fund is classified as a Sectoral/Thematic equity fund, investing in companies aligned with a specific sector or economic theme. The concentrated nature of such funds can drive strong outperformance when the underlying theme is in favour but can also amplify losses during sector downturns. The fund carries a Very High risk rating and should be treated as a tactical allocation rather than a core holding.
Mirae Asset Healthcare Fund NAV and AUM
The current NAV of the Mirae Asset Healthcare Fund Direct Growth plan is Rs 47.9. NAV is updated each trading day and reflects the closing market prices of the fund’s underlying securities. Always verify the most recent NAV on the AMC website or a registered mutual fund platform before placing any transaction.
The fund manages Rs 2,939.23 crore in assets, indicating a healthy investor base with meaningful conviction in its investment approach and adequate liquidity for most investor needs. Investors should track AUM trends alongside performance metrics when evaluating this fund.
Mirae Asset Healthcare Fund Returns: Performance Snapshot
| Period | Returns |
|---|---|
| 1 Month | 7.41% |
| 3 Months | 7.39% |
| 1 Year | 16.39% |
| 3 Years (Annualised) | 27.95% |
| 5 Years (Annualised) | 16.20% |
Performance for the Mirae Asset Healthcare Fund has been measured, delivering 16.39% over one year and 7.39% over three months. This level of return is broadly in line with its investment category average. Patient investors with a long-term horizon may find that consistent moderate compounding creates significant wealth over time, provided the underlying investment thesis remains intact.
Expense Ratio and Cost Efficiency
With an expense ratio of 0.45% per annum, the Mirae Asset Healthcare Fund Direct Growth plan offers a cost-competitive entry into its market segment. The direct plan eliminates intermediary commissions and, combined with the low expense ratio, creates a meaningful compounding advantage over the regular plan equivalent. Investors should always opt for the direct plan for superior long-term net returns.
Who Should Invest in Mirae Asset Healthcare Fund?
Investors confident in the long-term prospects of the Mirae Asset Healthcare Fund’s underlying investment theme can consider allocating to this fund as part of a satellite strategy. A minimum 5 to 7-year horizon and Very High risk tolerance are essential. The minimum SIP is Rs 99 and minimum lumpsum is Rs 5000. Conservative and first-time investors should avoid this fund entirely.
Key Risks to Consider
Timing Risk: Entry at peak valuations during a theme’s popularity can result in extended periods of underperformance. Thematic funds are highly sensitive to investor entry and exit timing.
Regulatory Risk: Sectors such as defence, pharma, and energy can be significantly impacted by government policy changes or regulatory shifts that are difficult to predict in advance.
Theme Obsolescence: Investment themes may lose relevance due to technological disruption, changing consumer behaviour, or structural shifts in the underlying industry.
Valuation Risk: Elevated valuations in the underlying investment universe can reduce future return potential even if the fundamental business performance of portfolio companies remains strong.
Download the Univest iOS App or Univest Android App to track this fund’s live NAV and manage your portfolio.
Conclusion
Steady returns, a competitive expense ratio of 0.45%, and an AUM of Rs 2,939.23 crore position the Mirae Asset Healthcare Fund as a reliable performer within its category. For patient investors with a 5 to 7-year horizon, its consistent management offers a dependable wealth-building vehicle. Ensure the fund fits your risk profile by consulting a SEBI-registered investment advisor.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Frequently Asked Questions
What is the current NAV of Mirae Asset Healthcare Fund?
Ans. The current NAV of the Mirae Asset Healthcare Fund Direct Growth plan is Rs 47.9. NAV is updated each trading day and reflects the closing market value of the fund’s underlying holdings. Always verify the most recent NAV on the AMC website or a SEBI-registered mutual fund platform before transacting.
What are the returns of Mirae Asset Healthcare Fund?
Ans. The fund has delivered a 1-year return of 16.39% and a 3-month return of 7.39%. The 3-year annualised return is 27.95% and the 5-year annualised return is 16.20%. Past performance does not guarantee future results and should be evaluated alongside the fund’s risk profile and benchmark comparison.
What is the expense ratio of Mirae Asset Healthcare Fund Direct Growth?
Ans. The expense ratio of the Mirae Asset Healthcare Fund Direct Growth plan is 0.45% per annum. The direct plan eliminates distributor commissions and is more cost-efficient than the regular plan. Investors should always opt for the direct plan to maximise long-term net returns through the compounding advantage of lower costs.
Is this fund suitable for conservative investors?
Ans. No. This fund carries a Very High risk rating due to concentrated exposure to a specific market segment or investment theme. It is not suitable for conservative investors or those with short investment timelines. A minimum 5 to 7-year horizon and a high risk tolerance are required prerequisites. Consult a SEBI-registered investment advisor before investing.
What is the minimum SIP amount for this fund?
Ans. The minimum monthly SIP is Rs 99 and the minimum lumpsum investment is Rs 5000. The low entry thresholds make the fund accessible across income levels. A regular SIP approach is recommended to average out entry costs over time, particularly given the high-volatility nature of this fund’s category.
What category and sub-category does this fund belong to?
Ans. This fund is a Sectoral/Thematic equity fund with a focused portfolio aligned to a specific sector or theme. It falls under the Sectoral / Thematic sub-category and is available as a direct growth plan, which eliminates distributor commissions and typically offers superior net returns compared to the regular plan.
Recent Articles

Why Is ICICI Lombard General Insurance Share Price Falling Key Reasons 2026
12 June 2026

Why Is IL&FS Engineering and Construction Share Price Falling Key Reasons 2026
12 June 2026

Why Is Igarashi Motors India Share Price Falling Key Reasons 2026
12 June 2026

Why Is JHS Svendgaard Laboratories Share Price Falling Key Reasons 2026
12 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Why Is ICICI Lombard General Insurance Share Price Falling Key Reasons 2026
Why Is IL&FS Engineering and Construction Share Price Falling Key Reasons 2026
Why Is Igarashi Motors India Share Price Falling Key Reasons 2026
Why Is JHS Svendgaard Laboratories Share Price Falling Key Reasons 2026
ESAF SFB Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
Popular this week
Why Is ICICI Lombard General Insurance Share Price Falling Key Reasons 2026
Why Is IL&FS Engineering and Construction Share Price Falling Key Reasons 2026
Why Is Igarashi Motors India Share Price Falling Key Reasons 2026
Why Is JHS Svendgaard Laboratories Share Price Falling Key Reasons 2026
ESAF SFB Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





